Navigation Links
CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
Date:7/21/2008

September meeting to focus on use of Zevalin as consolidation therapy after

remission induction in previously untreated patients with follicular

lymphoma

SEATTLE, July 22 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Company has scheduled a meeting with the U.S. Food and Drug Administration (FDA) in September to discuss the possibility of filing a supplemental Biologics License Application (sBLA) for use of Zevalin(R) ([90Y]-ibritumomab tiuxetan) as consolidation therapy after remission induction in previously untreated patients with follicular non-Hodgkin's lymphoma. The basis for the filing would be data from the First-line Indolent Trial that CTI recently gained access to through an agreement with Bayer Schering Pharma.

"We are pleased to have scheduled a meeting with the FDA to discuss a label expansion for Zevalin which could broaden its availability to patients," said James A. Bianco, M.D., President and CEO of Cell Therapeutics. "We continue to make progress with Zevalin on multiple fronts with clarity on reimbursement rates, deployment of our national sales team and now the opportunity to meet with the FDA to discuss possibly expanding the label for Zevalin."

About the Phase III First-line Indolent (FIT) Trial

The multinational, randomized phase III First-line Indolent Trial (FIT) evaluated the benefit and safety of a single infusion of Zevalin in patients with CD20-positive follicular non-Hodgkin's lymphoma who had achieved a partial response or a complete response after receiving standard first-line chemotherapy regimens. The FIT trial results were presented in one oral and two poster presentations at the American Society of Hematology (ASH) conference in December 2007. The FIT trial demonstrated that when used as a first-line consolidation therapy for patients with follicular non-Hodgkin's lymphoma, Zevalin significantly impro
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Threshold to Host Conference Call to Discuss Results From Clinical Presentations at European Cancer Conference (ECCO)
5. Most Women With HIV and Their Health Care Providers Have Not Discussed How HIV Might Affect Them Differently Than Men
6. APIC Conference to Discuss MRSA Elimination
7. ReachMD Broadcasts First-of-its-Kind Physician Peer-Peer Discussion on ENHANCE Trial
8. Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System
9. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
10. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
11. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... and BANGALORE , July 7, 2015 ... technology provider of innovative clinical trial data management solutions, ... Research Reports) recent publication named " EDC and eCOA ... ". ISR Reports is one of the leading providers ... this report evaluated 22 EDC and eCOA / ePRO ...
(Date:7/7/2015)... EnteroMedics Inc. (NASDAQ: ETRM ), a ... to treat obesity, metabolic diseases, and other gastrointestinal disorders, ... 32,000,000 units. Each unit consists of one share of ... one share of common stock at a purchase price ... in the offering would result in them beneficially owning ...
(Date:7/7/2015)... , July 7, 2015  Monopar Therapeutics LLC, ... compounds, announced that its co-founder and CEO, Chandler ... Council,s Education U.K. Alumni Entrepreneurial Award. The British Council ... , India , and ... outstanding achievements made by entrepreneurs who have leveraged their ...
Breaking Medicine Technology:Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... , , ... Orphan Drug Designation , SILVER SPRING, Md., Dec. 23 ... more transparent and accessible, the FDA has scheduled a series of ... unfamiliar with the process. The FDA can grant a special status, ...
... , , PHILADELPHIA, Dec. 23 URL Pharma today announced ... initiative designed to save patients money on their health insurance co-payment ... no more than $25 for a Colcrys prescription, which equates to ... the prevention and treatment of gout flares and for the treatment ...
Cached Medicine Technology:FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010 2URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 2URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 3URL Pharma Launches Co-Pay Assistance Program for Colcrys(R) 4
(Date:7/7/2015)... ... 07, 2015 , ... Bayco’s Nightstick® flashlight brand is expanding ... Nightstick XPP-5422GM , the world’s first Intrinsically Safe Permissible LED Dual-Light™ combination ... on its clip. The new Nightstick XPP-5422GM is now approved for global use ...
(Date:7/7/2015)... MI and Wellesley, MA (PRWEB) , ... July ... ... National Institute of Whole Health (NIWH) have jointly announced a partnership ... professionals addressing unsolved, chronic medical case studies. The study will be conducted with ...
(Date:7/7/2015)... ... July 07, 2015 , ... RadSite™, a ... designated by the Centers for Medicare and Medicaid Services (CMS), announces that it ... with mobile devices. , The most effective websites are those that provide timely ...
(Date:7/7/2015)... ... 07, 2015 , ... Nationally-renowned attorneys in the realm of ... Invokana Ketoacidosis Lawsuit Center . The website provides information on Invokana side ... wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, heart attack, ...
(Date:7/7/2015)... PA (PRWEB) , ... July 07, 2015 , ... ... manufacturer of safety signs and safety labels, has been featured in the latest ... for electrical engineering professionals. , In Compliance delivers the latest news, ...
Breaking Medicine News(10 mins):Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 2Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 3Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 3Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 2Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 3Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 4
... and Mark Spitz Educate Americans on the Importance of Specialized ... ... years past,each has battled for Olympic gold. Today they are fighting a ... in a new era in healthcare, Olympic gold medal athletes and,Medco Health ...
... Chest Physicians for Lung Cancer ... ... Inc.,(TSX: NDQ), a developer of real-time medical imaging systems and image,guided ... PINPOINT(TM) endoscopic imaging system at the Annual Meeting of,American College of ...
... are healthy,purchasing disability insurance can seem counter-intuitive. Purchasing,disability ... to earn a living, says Frank N. Darras, ... (Photo: http://www.newscom.com/cgi-bin/prnh/20070717/NYFNSC02 ) "Since ... make sure you,buy the right type of policy, ...
... Fla., Oct. 16 Many people know that you ... are exercising. But it can be used,in other ways, ... of the health of,your cardiovascular system," says Stan Reents, ... A person,s heart rate increases as exercise intensity ...
... GAITHERSBURG, Md., Oct. 16 Introducing Wordsies(TM) for,babies ... for babies and toddlers that "speak" meaningful and ... a mother of three who,wanted to allow other ... while,trying not to offend anyone. To view ...
... Experienced Sales Executive to Lead Growing Medical Device ... Bacchus Vascular Inc., a,leading provider of innovative medical ... the minimally invasive treatment of,deep vein thrombosis (DVT) ... has named Scott Cramer to the position of ...
Cached Medicine News:Health News:Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the 'Tour of Champions' 2Health News:Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the 'Tour of Champions' 3Health News:Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the 'Tour of Champions' 4Health News:Six Olympic Legends Battling Chronic Diseases Lead Revolution in Advancing Pharmacy Care as Medco Launches the 'Tour of Champions' 5Health News:Novadaq launches PINPOINT: Company's first minimally invasive imaging system 2Health News:Novadaq launches PINPOINT: Company's first minimally invasive imaging system 3Health News:Novadaq launches PINPOINT: Company's first minimally invasive imaging system 4Health News:Why Healthy People Should Consider Individual Disability Insurance 2Health News:Exercise And Health: Use Your Heart Rate As a Guide 2Health News:Photo: Introducing a New Line of Baby and Toddler Shirts that Can Help Protect Innocent Babies During Flu Season 2Health News:Bacchus Vascular Names Scott Cramer as President and CEO 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: